Cécile Tomowiak

1.2k total citations
45 papers, 404 citations indexed

About

Cécile Tomowiak is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Cécile Tomowiak has authored 45 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 24 papers in Pathology and Forensic Medicine and 13 papers in Hematology. Recurrent topics in Cécile Tomowiak's work include Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (24 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Cécile Tomowiak is often cited by papers focused on Chronic Lymphocytic Leukemia Research (33 papers), Lymphoma Diagnosis and Treatment (24 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Cécile Tomowiak collaborates with scholars based in France, United States and Australia. Cécile Tomowiak's co-authors include Xavier Leleu, Stéphanie Guidez, Stéphanie Poulain, Charles Herbaux, Véronique Leblond, Stéphane Leprêtre, Lydia Roy, François Guilhot, Thierry Langlois and Jason A. Mills and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Cancer Research.

In The Last Decade

Cécile Tomowiak

40 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cécile Tomowiak France 11 244 189 131 103 99 45 404
Fontanet Bijou France 11 217 0.9× 234 1.2× 131 1.0× 117 1.1× 233 2.4× 46 467
M. P. A. Lyttelton United Kingdom 10 151 0.6× 154 0.8× 157 1.2× 81 0.8× 144 1.5× 13 401
Francesco Autore Italy 11 169 0.7× 113 0.6× 94 0.7× 49 0.5× 79 0.8× 54 316
Abigail S. Kelliher United States 7 178 0.7× 161 0.9× 135 1.0× 69 0.7× 90 0.9× 9 369
Lidija Čevreska North Macedonia 9 169 0.7× 153 0.8× 147 1.1× 31 0.3× 104 1.1× 40 410
Dolores Caballero Spain 9 124 0.5× 112 0.6× 305 2.3× 107 1.0× 123 1.2× 17 428
Hélène Demarquette France 8 116 0.5× 158 0.8× 168 1.3× 80 0.8× 199 2.0× 20 371
Thérèse Aurran‐Schleinitz France 12 178 0.7× 152 0.8× 85 0.6× 61 0.6× 109 1.1× 26 397
M. Lenoci Italy 7 212 0.9× 190 1.0× 110 0.8× 70 0.7× 76 0.8× 10 362

Countries citing papers authored by Cécile Tomowiak

Since Specialization
Citations

This map shows the geographic impact of Cécile Tomowiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Tomowiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Tomowiak more than expected).

Fields of papers citing papers by Cécile Tomowiak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cécile Tomowiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Tomowiak. The network helps show where Cécile Tomowiak may publish in the future.

Co-authorship network of co-authors of Cécile Tomowiak

This figure shows the co-authorship network connecting the top 25 collaborators of Cécile Tomowiak. A scholar is included among the top collaborators of Cécile Tomowiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cécile Tomowiak. Cécile Tomowiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roos‐Weil, Damien, Cécile Tomowiak, Stéphanie Poulain, et al.. (2025). Waldenström’s macroglobulinemia: The LYSA pragmatic guidelines. European Journal of Cancer. 232. 116120–116120.
2.
Tomowiak, Cécile, Stéphanie Poulain, Pierre Feugier, et al.. (2024). Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia. Annals of Hematology. 104(1). 685–690. 2 indexed citations
3.
Gombert, Jean‐Marc, André Herbelin, Cécile Tomowiak, et al.. (2024). Sipavibart (AZD-3152), a COVID-19 Pre-Exposure Prophylaxis in Myeloma Treated with BCMA/CD3 Bispecific Antibodies. Blood. 144(Supplement 1). 7222–7222.
4.
Talaulikar, Dipti, Cécile Tomowiak, Elise Toussaint, et al.. (2023). Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. 37(4). 787–799. 3 indexed citations
5.
Durot, Éric, Cécile Tomowiak, Elise Toussaint, et al.. (2022). Transformed Waldenström Macroglobulinemia: Update on Diagnosis, Prognosis and Treatment. SHILAP Revista de lepidopterología. 3(4). 650–662. 1 indexed citations
6.
Maître, Elsa, Cécile Tomowiak, Fontanet Bijou, et al.. (2022). Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients. Cancers. 14(8). 1904–1904. 10 indexed citations
7.
Leblond, Véronique, Cécile Tomowiak, Kamel Laribi, et al.. (2022). Maladie de Waldenström : actualités et perspectives en 2022. Bulletin du Cancer. 110(1). 88–100. 1 indexed citations
8.
Tomowiak, Cécile, Stéphanie Poulain, Charles Herbaux, et al.. (2021). Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia. Blood Advances. 5(9). 2438–2446. 21 indexed citations
9.
Tomowiak, Cécile, et al.. (2021). Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database. Frontiers in Pharmacology. 12. 769315–769315. 11 indexed citations
10.
Lévy, Anthony, et al.. (2020). The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma. Frontiers in Oncology. 10. 676–676. 4 indexed citations
11.
Tomowiak, Cécile, et al.. (2019). Maladie de Waldenström. La Presse Médicale. 48(7-8). 832–841. 1 indexed citations
12.
Javaugue, Vincent, Elise Gand, Sophie Chauvet, et al.. (2019). Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders. Kidney International. 96(1). 94–103. 16 indexed citations
13.
Tomowiak, Cécile, et al.. (2018). Working Toward a Genomic Prognostic Classification of Waldenström Macroglobulinemia. Hematology/Oncology Clinics of North America. 32(5). 753–763. 5 indexed citations
14.
Guidez, Stéphanie, Cécile Tomowiak, Brigitte Dreyfus, et al.. (2018). Oral CHOP-like Chemotherapy in Elderly Patients with High-Grade Non Hodgkin B Cell Lymphoma. Blood. 132(Supplement 1). 4231–4231. 1 indexed citations
15.
Poulain, Stéphanie, Christophe Roumier, Elisabeth Bertrand, et al.. (2017). TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia. Clinical Cancer Research. 23(20). 6325–6335. 62 indexed citations
16.
Rabian, Florence, Raphaël Porcher, Flore Sicre de Fontbrune, et al.. (2016). Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis. Biology of Blood and Marrow Transplantation. 22(9). 1721–1724. 7 indexed citations
17.
Antony‐Debré, Iléana, Nathalie Balayn, Dominique Bluteau, et al.. (2014). Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. Blood. 125(6). 930–940. 71 indexed citations
18.
Cornet, Édouard, Cécile Tomowiak, Aline Schmidt, et al.. (2014). Long‐term follow‐up and second malignancies in 487 patients with hairy cell leukaemia. British Journal of Haematology. 166(3). 390–400. 42 indexed citations
19.
Guilhot, François, Lydia Roy, & Cécile Tomowiak. (2012). Current treatment strategies in chronic myeloid leukemia. Current Opinion in Hematology. 19(2). 102–109. 12 indexed citations
20.
Feugier, Patrick, Cécile Tomowiak, Nicolas Daguindau, & Aurore Perrot. (2007). Critères d'éligibilité des patients pour un traitement par immunoglobuline humaine normale intraveineuse. La Revue de Médecine Interne. 28. 7–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fontanet Bijou Breakdown of academic impact, for papers by M. P. A. Lyttelton Breakdown of academic impact, for papers by Francesco Autore Breakdown of academic impact, for papers by Abigail S. Kelliher Breakdown of academic impact, for papers by Lidija Čevreska Breakdown of academic impact, for papers by Dolores Caballero Breakdown of academic impact, for papers by Hélène Demarquette Breakdown of academic impact, for papers by Thérèse Aurran‐Schleinitz Breakdown of academic impact, for papers by M. Lenoci
Rankless by CCL
2026